Status:
COMPLETED
Duchenne Muscular Dystrophy Clinical Trial
Lead Sponsor:
Alan Neuromedical Technologies, LLC
Conditions:
Duchenne Muscular Dystrophy
Eligibility:
All Genders
8-20 years
Phase:
NA
Brief Summary
The primary objective of this investigation is to assess the effectiveness of transcutaneous electrical nerve stimulation applied using VECTTOR to reduce the symptoms of Duchenne Muscular Dystrophy an...
Detailed Description
Muscle Strength and Joint Range of Motion Testing - All muscle and joint testing was performed at the MedCenter Therapy clinic in Houston, Texas. JTech computerized testing system was utilized includi...
Eligibility Criteria
Inclusion
- Participants must have Duchenne Muscular Dystrophy diagnosis as confirmed by licensed physician, wheelchair bound, \& age 8 - 20 years old.
Exclusion
- Active cancer in the area of application of the treatment, infection, skin infection, pregnancy, thrombophlebitis, pacemaker, amputation of any part of feet or hands, taking steroids. In addition, the participant may not be in any other clinical trial during the time they are in this study.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT01874275
Start Date
June 1 2013
End Date
September 1 2014
Last Update
May 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alan Neuromedical
Houston, Texas, United States, 77004